About Us
Oriel Research Therapeutics (ORT) is a bioinformatics company that provides services both for harmonized real-world patients’ derived genomic data, AI based model development, and early detection tests for cancer and other diseases using its AI-based platform.
​
ORT's technology utilizes a state-of-the-art cloud-based software platform, which processes large omic, like gene expressions, and clinical data to build the ORT database. The database is processed with proprietary Artificial Intelligence/Machine Learning (Al/ML) models.
​
The ORT database includes over 1 million RNA-seq profiles from in-vivo and in-vitro patients’ samples with matching clinical data.
​
Oriel Research Therapeutics allows easy access to its large-scale, harmonized, real-world data (RWD) and to its proprietary pipelines to allow a quick adoption of evidence-based hypotheses for diagnosis, therapy matching, and target development.
ORT is a J&J innovation lab company and is located in Cambridge, MA
Eila Arich ME
Founder, CEO
Microsoft
Technion, Broad Institute, MGH, Whitehead Institute,
Stanford
Noam Shoresh PhD
Science, Bioinformatics
Harvard Medical School, Broad Institute, MGH, The Hebrew University